WHO ICTRP trial
Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic…
NCT00960050 · NIH Clinical Trials · Not recruiting
Key facts
| Trial ID | NCT00960050 |
|---|---|
| Public title | Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic Anemia Treated With Dapsone |
| Scientific title | Dapsone Induced Methemoglobinemia Study (DIMS) |
| Primary sponsor | Vanderbilt-Ingram Cancer Center |
| Secondary sponsors | National Cancer Institute (NCI) |
| Registry | NIH Clinical Trials |
| Recruitment status | Not recruiting |
| Study type | Observational |
| Countries | United States |
| Conditions | Leukemia;Lymphoma;Methemoglobinemia;Nonmalignant Neoplasm |
| Interventions | Genetic: polymorphism analysis;Other: laboratory biomarker analysis;Other: medical chart review;Procedure: assessment of therapy complications |
| Registration date | Aug 14, 2009 |
| Target size | 173 |
| Secondary IDs | VU-VICC-PED-0937;CDR0000651820 |
| Registry page | clinicaltrials.gov |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: